STOCK TITAN

Maravai CFO has 5,466 shares withheld for taxes

A separate 126,352-share transfer from direct ownership to his family trust was exempt from reporting under Rule 16a-13.

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Maravai LifeSciences Holdings, Inc. Chief Financial Officer Rajesh Asarpota had 5,466 shares of Class A common stock withheld on October 30, 2026, to satisfy tax-withholding obligations tied to vesting restricted stock unit awards; the reported price was $8.46 per share. Following the transaction, he beneficially owned 286,203 shares directly and 126,352 shares indirectly through his family trust.

Insider Asarpota Rajesh
Role Chief Financial Officer
Type Security Shares Price Value
Tax Withholding Class A Common Stock F1, F2 5,466 $8.46 $46K
Holding Class A Common Stock F2 -- -- --
Holdings After Transaction: Class A Common Stock — 286,203 shares (Direct); Class A Common Stock — 126,352 shares (Indirect, By Family Trust)
Footnotes (2)
  1. F1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
  2. F2. The shares of Class A Common Stock beneficially owned by the reporting person directly and indirectly following the transaction reported herein reflect a transfer of 126,352 shares previously reported as directly owned by the reporting person to the reporting person's family trust, which transfer of shares was exempt from reporting pursuant to Rule 16a-13.
Shares withheld 5,466 shares Tax withholding connected with vesting restricted stock unit awards on October 30, 2026
Reported price $8.46 per share Withheld Class A common stock on October 30, 2026
Direct holdings 286,203 shares Following the transaction
Indirect holdings 126,352 shares Held through his family trust following the transaction
restricted stock unit awards financial
"vesting of restricted stock unit awards"
Restricted stock unit awards are company promises to deliver a specific number of shares to employees or service providers in the future once conditions—such as staying with the company for a set time or meeting performance targets—are met. They matter to investors because when the promises convert into actual shares they increase the total share count and can reduce earnings per share, while also aligning recipients’ interests with stock performance much like deferred pay that turns into ownership if goals are met.
tax withholding obligations financial
"to satisfy tax withholding obligations"
Rule 16a-13 regulatory
"exempt from reporting pursuant to Rule 16a-13"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many MRVI shares did the CFO have withheld, and at what price?

Rajesh Asarpota had 5,466 shares withheld at a reported price of $8.46 per share on October 30, 2026. The withholding satisfied tax obligations connected with vesting restricted stock unit awards.

What happened to 126,352 MRVI shares?

Rajesh Asarpota transferred 126,352 shares previously reported as directly owned to his family trust. The transfer was exempt from reporting pursuant to Rule 16a-13.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Asarpota Rajesh

(Last)(First)(Middle)
C/O MARAVAI LIFESCIENCES HOLDINGS, INC.
10770 WATERIDGE CIRCLE, SUITE 200

(Street)
SAN DIEGO CALIFORNIA 92121

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
MARAVAI LIFESCIENCES HOLDINGS, INC. [ MRVI ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
10/30/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock10/30/2026F5,466(1)D$8.46286,203(2)D
Class A Common Stock126,352(2)IBy Family Trust
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents shares withheld to satisfy tax withholding obligations in connection with the vesting of restricted stock unit awards held by the reporting person.
2. The shares of Class A Common Stock beneficially owned by the reporting person directly and indirectly following the transaction reported herein reflect a transfer of 126,352 shares previously reported as directly owned by the reporting person to the reporting person's family trust, which transfer of shares was exempt from reporting pursuant to Rule 16a-13.
Remarks:
/s/ Kurt Oreshack, by power of attorney for Rajesh Asarpota11/02/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading